(WTKN.OB)WellCity, Inc. Unveils WellCity Market For Health and Long-term Wealth

Posted on 15. Jul, 2010 by PublicWire in Medical   

(PublicWire.com Press Release)WellCity, Inc. (http://www.wellcity.com), a wellness-related social network and subsidiary of WellTek Inc. (OTCBB: WTKN), today unveiled WellCity Market, its network marketing platform, calling all consumers and network marketers to be one of the first to join this ground-breaking opportunity to create optimum health and long-term wealth by getting social inside WellCity.

“Until now, social network users have had no way to leverage their personal network as a direct income opportunity. Today, we’ve changed that,” said David George, CEO of WellCity. “We are the first social network to offer actual money to its users. With the integration of WellCity Market, our WellCity ‘residents’ have an unprecedented opportunity to help others achieve optimal health, while they earn income from the purchases made by their network of family and friends or ‘neighbors.’ It’s a simple idea: users get paid every time their ‘neighbors’ make a purchase inside WellCity Market.”

WellCity Market offers a breadth of natural products to help others live a more enriched life physically, spiritually and financially. The technology of online social networking provides the single most effective medium today for creating long-term wealth and for teaching people about new products and services that help people feel better, lose weight, prevent disease and become younger and stronger even as people grow older.

According to world-renowned economist Paul Zane Pilzer, the emerging Wellness Industry has quickly become the hottest trend in the world today and it is predicted to reach $1 trillion by 2012. Furthermore, according to Direct Selling News, well over $70 billion dollars in revenue was generated in 2009 by the top 100 network marketing companies. “The convergence of the Wellness Industry with Network Marketing and Social Networking provides an extraordinary opportunity for our residents in WellCity, as well our shareholders; we are creating the perfect storm of opportunity,” said Randy Lubinsky, Chairman and CEO of WellTek. “It’s comparable to merging Amway with Facebook.”

WTKN.OB, WTKN.OTCBB, WTKN

For all the latest in small cap news, videos, and information, visit us online at PublicWire.com, or call us, toll free, at 888-843-1412.

(ROHI.OB)Rotech Healthcare Inc. Accepts 17 Medicare & Medicaid Contracts

Posted on 14. Jul, 2010 by PublicWire in Medical   

(PublicWire.com Press Release)Rotech Healthcare Inc. (OTCBB: ROHI) today announced that it has accepted 17 contracts awarded by the Centers for Medicare & Medicaid Services (”CMS”) in the Round 1 Rebid of the national Medicare Competitive Bidding Program. The Round 1 Rebid included nine metropolitan statistical areas (”MSAs”). Only contracted suppliers can service Medicare patients for the competitively-bid product categories in these locations, with a few exceptions. The new contracts awarded in Round 1 have a three-year term and are scheduled to take effect on January 1, 2011. Rotech has accepted the following contracts:

* 6 MSAs for oxygen supplies and equipment;

* 6 MSAs for enteral nutrients, equipment and supplies;

* 3 MSAs for CPAP, RADs and related supplies and accessories; and

* 2 MSAs for standard power wheelchairs, scooters and related accessories.

CMS continues to award contracts through September and, therefore, additional contracts may be awarded.

“We are pleased with our success in the Round 1 Rebid of the national competitive bidding program and we look forward to further growth and expansion of our existing presence in these initial cities,” commented Philip L. Carter, Rotech’s President and Chief Executive Officer. “The new payment rates for our six oxygen contracts averaged approximately 30% off the current applicable Medicare payment rates,” Mr. Carter continued. “Not assuming any market share gains, the application of the new competitive bid rates to our existing patient base in these nine MSAs reduces our revenue by approximately $900,000 in the first quarter of 2011,” he explained, adding that, “We believe, however, that our market share gains in the cities where we were awarded contracts will more than offset the reductions in reimbursement rates over time.”

ROHI.OB, ROHI.OTCBB, ROHI

For all the latest in small cap news, videos, and information, visit us online at PublicWire.com, or call us, toll free, at 888-843-1412.

(TSNI.OB)TechniScan’s Incredible New Product is More Comfortable, Faster, and More Effective

Posted on 12. Jul, 2010 by PublicWire in Featured   

(PublicWire.com News Release)Incredible New Product is More Comfortable, Faster, and More Effective

TechniScan (TSNI.OB), a medical device company engaged in the development and commercialization of an automated 3D breast ultrasound imaging system, aims to add comfort to an otherwise unpleasant experience.

TechniScan has created their Warm Bath Ultrasound (WBU) system, designed to capture three-dimensional images of the breast as a woman lies prone on a table while state-of-the-art ultrasound technology in a warm water tank images the breast anatomy. The revolutionary new method of imaging that TechnicScan created produces information and whole breast images that are not available with traditional reflection ultrasound or whole breast ultrasound systems presently on the market.

TechniScan Chief Medical Officer, Dr. John Klock, asserts that the most recently completed clinical work continues to support that refraction-corrected reflection images highlight connective tissue features within the breast, whereas the speed-of-sound images show fibroglandular, ductal and terminal lobular units with high resolution.

“We have clearly demonstrated that the system can reliably reproduce images based on reflection and sound transmission and that those images will have significant clinical utility,” said David Robinson TechniScan’s president and CEO.

“Volumetric whole-breast imaging provides a substantial practical advantage over conventional very-small-field-of-view sonography. We are greatly aided by the ability to produce repeatable whole-breast comparisons – left to right and present to past. These comparisons are the nuts and bolts of breast imaging, by any modality,” said Michael Andre, Ph.D., adjunct professor of radiology and director of medical physics at University of California, San Diego School of Medicine.

Building on this prior clinical work, the current clinical studies in Freiberg, Germany, San Diego and Rochester will involve at least 500 women with various types of breast lesions. Major objectives of the 12-month study will be to compare WBU to conventional breast sonography and MRI as well as to examine the WBU system’s ability to differentiate between normal, benign and malignant breast tissue. These clinical studies in the U.S. are funded by a Small Business Innovation Research Grant (SBIR) from the National Cancer Institute.

Researchers involved in the study will also utilize TechniScan’s groundbreaking imaging network, which provides them with the ability to archive, store, and retrieve WBU images and relevant medical records and to collaborate with other researchers at sites in Freiburg, Germany, Salt Lake City and Rochester, Minnesota.

Recently the company announced it filed a certificate of amendment to implement a one-for-four reverse stock split of the company’s issued and outstanding common stock.
The reverse stock split, which was previously approved by the company’s board of directors and stockholders, will take effect with the opening of the markets on Monday, June 28, 2010, subject to approval by FINRA. Trading of TechniScan’s common stock will continue on a reverse stock split-adjusted basis.

The board believes that the reverse stock split will increase market price, help attract long term investors and increase investor interest. The increase in stock price will also allow the company to meet the requirements to be accepted to the American Stock Exchange (AMEX), should the company pursue an application for such listing.

TechniScan stockholders will receive one new TechniScan share for every four shares that they held prior to the split, and all fractional shares will be rounded up to the next whole share on a certificate basis only. As a result of the reverse stock split, the number of shares of the company’s common stock outstanding will be reduced from approximately $82.9 million to approximately $20.7 million shares.

To indicate that the reverse stock split has occurred, a “D” will be added to the company’s trading symbol, such that the post-split common stock will trade under the symbol “TSNID” beginning on June 28, 2010 for a period of 20 trading days, after which TechniScan’s common stock will resume trading under the symbol “TSNI.” The new CUSIP number for the company’s post-split common stock will be 87855G 206

For More Information visit: www.techniscanmedical.com.

TSNI.OB, TSNI.OTCBB, TSNI

For all the latest in small cap news, videos, and information, visit us online at PublicWire.com, or call us, toll free, at 888-843-1412.

(TSNI.OB) PublicWire.com News: TechniScan’s Innovative Technology Company Believed To Be The Next Hottest Medical Stock!

Posted on 08. Jul, 2010 by PublicWire in Featured   

Incredible New Product is More Comfortable, Faster, and More Effective

PublicWire.com Special Report: TechniScan (TSNI.OB), a medical device company engaged in the development and commercialization of an automated 3D breast ultrasound imaging system, aims to add comfort to an otherwise unpleasant experience.

TechniScan has created their Warm Bath Ultrasound (WBU) system, designed to capture three-dimensional images of the breast as a woman lies prone on a table while state-of-the-art ultrasound technology in a warm water tank images the breast anatomy. The revolutionary new method of imaging that TechnicScan created produces information and whole breast images that are not available with traditional reflection ultrasound or whole breast ultrasound systems presently on the market.

TechniScan Chief Medical Officer, Dr. John Klock, asserts that the most recently completed clinical work continues to support that refraction-corrected reflection images highlight connective tissue features within the breast, whereas the speed-of-sound images show fibroglandular, ductal and terminal lobular units with high resolution.

“We have clearly demonstrated that the system can reliably reproduce images based on reflection and sound transmission and that those images will have significant clinical utility,” said David Robinson TechniScan’s president and CEO.

“Volumetric whole-breast imaging provides a substantial practical advantage over conventional very-small-field-of-view sonography. We are greatly aided by the ability to produce repeatable whole-breast comparisons – left to right and present to past. These comparisons are the nuts and bolts of breast imaging, by any modality,” said Michael Andre, Ph.D., adjunct professor of radiology and director of medical physics at University of California, San Diego School of Medicine.

Building on this prior clinical work, the current clinical studies in Freiberg, Germany, San Diego and Rochester will involve at least 500 women with various types of breast lesions. Major objectives of the 12-month study will be to compare WBU to conventional breast sonography and MRI as well as to examine the WBU system’s ability to differentiate between normal, benign and malignant breast tissue. These clinical studies in the U.S. are funded by a Small Business Innovation Research Grant (SBIR) from the National Cancer Institute.

Researchers involved in the study will also utilize TechniScan’s groundbreaking imaging network, which provides them with the ability to archive, store, and retrieve WBU images and relevant medical records and to collaborate with other researchers at sites in Freiburg, Germany, Salt Lake City and Rochester, Minnesota.

Recently the company announced it filed a certificate of amendment to implement a one-for-four reverse stock split of the company’s issued and outstanding common stock.
The reverse stock split, which was previously approved by the company’s board of directors and stockholders, will take effect with the opening of the markets on Monday, June 28, 2010, subject to approval by FINRA. Trading of TechniScan’s common stock will continue on a reverse stock split-adjusted basis.

The board believes that the reverse stock split will increase market price, help attract long term investors and increase investor interest. The increase in stock price will also allow the company to meet the requirements to be accepted to the American Stock Exchange (AMEX), should the company pursue an application for such listing.

TechniScan stockholders will receive one new TechniScan share for every four shares that they held prior to the split, and all fractional shares will be rounded up to the next whole share on a certificate basis only. As a result of the reverse stock split, the number of shares of the company’s common stock outstanding will be reduced from approximately $82.9 million to approximately $20.7 million shares.

To indicate that the reverse stock split has occurred, a “D” will be added to the company’s trading symbol, such that the post-split common stock will trade under the symbol “TSNID” beginning on June 28, 2010 for a period of 20 trading days, after which TechniScan’s common stock will resume trading under the symbol “TSNI.” The new CUSIP number for the company’s post-split common stock will be 87855G 206

For More Information visit: www.techniscanmedical.com.

Forward Looking Statements
Certain statements in this Special Report that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified by the use of words such as “anticipate, “believe,” “expect,” “future,” “may,” “will,” “would,” “should,” “plan,” “projected,” “potential,” “intend,” and similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of TechniScan Inc. (the “company”) to be materially different from those expressed or implied by such forward-looking statements. The company’s future operating results are dependent upon many factors, including risk factors discussed in the company’s periodic filings with the Securities and Exchange Commission, which are available for review at www.sec.gov, including the company’s Annual Report on Form 10-K filed on March 22, 2010. The company undertakes no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise.

TSNID, TSNID.OB, TSNID.OTCBB
TSNI, TSNI.OB, TSNI.OTCBB